The US Drug Enforcement Administration rolled out a dispensing policy that’s arbitrary, capricious, and was adopted without notice and comment rulemaking required by the Administrative Procedure Act, the company said in a complaint filed in the US District Court for the Eastern District of Texas on Thursday. The court should set aside DEA’s policy, the retailer said.
DEA tightened its enforcement of the Controlled ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.